Hepatocyte growth factor reduces sensitivity to the epidermal growth factor receptor-tyrosine kinase inhibitor, gefitinib, in lung adenocarcinoma cells harboring wild-type EGFR (Q37086009)
Jump to navigation
Jump to search
scientific article published on 22 February 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Hepatocyte growth factor reduces sensitivity to the epidermal growth factor receptor-tyrosine kinase inhibitor, gefitinib, in lung adenocarcinoma cells harboring wild-type EGFR |
scientific article published on 22 February 2016 |
Statements
1 reference
Hepatocyte growth factor reduces sensitivity to the epidermal growth factor receptor-tyrosine kinase inhibitor, gefitinib, in lung adenocarcinoma cells harboring wild-type EGFR (English)
1 reference
Hua Yang
1 reference
Rong Wang
1 reference
Shunli Peng
1 reference
Longhua Chen
1 reference
Qi Li
1 reference
Wei Wang
1 reference
22 February 2016
1 reference
1 reference
16273-16281
1 reference
Identifiers
1 reference
1 reference
1 reference